Hepatitis C

Hepatitis C is a blood-borne virus that infects the liver, where it causes significant inflammation, damage and disruption of normal liver function. According to estimates by the World Health Organization, around 3 to 4 million people worldwide are infected with hepatitis C every year.
What is Hepatitis C?

Hepatitis C infection is a liver infection caused by the Hepatitis C virus. Infection with hepatitis C may damage the liver leading to chronic infection.

Read More

Overview

Feature Articles

Latest Hepatitis C News and Research

Phosphatidic acid is a key common substrate for hepatitis C and SARS-CoV-2 replication

Phosphatidic acid is a key common substrate for hepatitis C and SARS-CoV-2 replication

New drug-like compound could effectively block a critical step in malaria parasite life cycle

New drug-like compound could effectively block a critical step in malaria parasite life cycle

Study reveals how oral antiviral drug works to attack SARS-CoV-2 virus

Study reveals how oral antiviral drug works to attack SARS-CoV-2 virus

Natural products a rich source for novel antiviral compounds

Natural products a rich source for novel antiviral compounds

Applications of nanoparticles in combating COVID-19

Applications of nanoparticles in combating COVID-19

Hepatitis C antivirals synergize with remdesivir to inhibit SARS-CoV-2 in vitro

Hepatitis C antivirals synergize with remdesivir to inhibit SARS-CoV-2 in vitro

ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa

ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa

Curcumin nanosystems could be powerful COVID-19 therapeutics

Curcumin nanosystems could be powerful COVID-19 therapeutics

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

ACE2 homology in laboratory and wild animals

ACE2 homology in laboratory and wild animals

Developing orally administrable drugs to combat SARS-CoV-2

Developing orally administrable drugs to combat SARS-CoV-2

Selecting SARS-CoV-2 inhibitors in human airway epithelial cells

Selecting SARS-CoV-2 inhibitors in human airway epithelial cells

Drugging RNA synthesis in SARS-CoV-2 as novel therapeutic avenue

Drugging RNA synthesis in SARS-CoV-2 as novel therapeutic avenue

High throughput screening for COVID-19 with the VOYAGER pipette

High throughput screening for COVID-19 with the VOYAGER pipette

SARS-CoV-2 infection is circadian

SARS-CoV-2 infection is circadian

Undocumented pregnant women in Finland receive inadequate prenatal care, study shows

Undocumented pregnant women in Finland receive inadequate prenatal care, study shows

Online platforms can increase drug overdose

Online platforms can increase drug overdose

Scientists discover how novel pathogens promote colorectal cancer development

Scientists discover how novel pathogens promote colorectal cancer development

WHA’s president outlines plans to improve treatments for patients with hepatitis

WHA’s president outlines plans to improve treatments for patients with hepatitis

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells